Phenylpiracetam – (77472-70-9)

Phenylpiracetam, also known as Phenotropil and Fonturacetam, is a phenylated derivative of the nootropic drug piracetam. It is a central nervous system stimulant and nootropic agent belonging to the racetam family of drugs. Initially developed in Russia in 1983, phenylpiracetam is used to enhance cognitive functions, particularly in individuals with cognitive decline due to organic causes.

Phenylpiracetam is known for its potent stimulant and nootropic properties, with effects that can be up to 30-60 times stronger than those of piracetam. It is commonly used to improve memory, attention, and mental energy. The drug is believed to work by increasing the release of acetylcholine in the brain, which is crucial for memory and learning. Additionally, it acts as a selective dopamine reuptake inhibitor, enhancing dopamine levels and contributing to its stimulating effects.

Research on phenylpiracetam suggests it may have potential in treating conditions beyond cognitive enhancement, such as stroke and glaucoma. However, further studies are needed to fully understand its mechanisms of action and long-term effects.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Phenylpiracetam
https://www.medchemexpress.com/phenylpiracetam.html
https://www.medkoo.com/products/8074
https://psychonautwiki.org/wiki/Phenylpiracetam